Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Barnard

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Antiviral Research|July 13, 2001
Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201R W Sidwell, D F Smee, J H Huffman, et al.
Hematological Oncology|January 1, 1994
Prognosis in low grade non-Hodgkin's lymphoma: relevance of the number of sites involved, absolute lymphocyte count and serum immunoglobulin levelD Parker, D L Alison, D L Barnard, et al.
Antiviral Chemistry & Chemotherapy|January 5, 2002
Inhibition of measles virus replication by 5'-nor carbocyclic adenosine analoguesD L Barnard, V D Stowell, K L Seley, et al.
British Journal of Haematology|June 1, 1996
Mobilization of Philadelphia-negative peripheral blood mononuclear cells in chronic myeloid leukaemia using hydroxyurea and G-CSF (filgrastim)R J Johnson, R G Owen, J A Child, et al.
Clinical Molecular Pathology|April 1, 1996
Detection of clonal immunoglobulin gene rearrangements in the peripheral blood progenitor cells of patients with multiple myeloma: the potential role of purging with CD34 positive selectionR G Owen, A P Haynes, P A Evans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 1998
Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin's lymphoma. Central Lymphoma GroupN P Bailey, N S Stuart, E M Bessell, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Antiviral Research|July 13, 2001
Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201R W Sidwell, D F Smee, J H Huffman, et al.
Hematological Oncology|January 1, 1994
Prognosis in low grade non-Hodgkin's lymphoma: relevance of the number of sites involved, absolute lymphocyte count and serum immunoglobulin levelD Parker, D L Alison, D L Barnard, et al.
Antiviral Chemistry & Chemotherapy|January 5, 2002
Inhibition of measles virus replication by 5'-nor carbocyclic adenosine analoguesD L Barnard, V D Stowell, K L Seley, et al.
British Journal of Haematology|June 1, 1996
Mobilization of Philadelphia-negative peripheral blood mononuclear cells in chronic myeloid leukaemia using hydroxyurea and G-CSF (filgrastim)R J Johnson, R G Owen, J A Child, et al.
Clinical Molecular Pathology|April 1, 1996
Detection of clonal immunoglobulin gene rearrangements in the peripheral blood progenitor cells of patients with multiple myeloma: the potential role of purging with CD34 positive selectionR G Owen, A P Haynes, P A Evans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 1998
Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin's lymphoma. Central Lymphoma GroupN P Bailey, N S Stuart, E M Bessell, et al.
Pageof 7